Dup15q Syndrome Market Expected to Experience Steady Growth at a CAGR of 23.96% During the Study Period 20170-30 in the 7MM, says DelveInsight
Soticlestat (OV935/TAK-935), is expected to get launched in the forecasted period (2021-2030).
Soticlestat will enter the US Dup15q Syndrome market in
2024 and the EU and Japan Dup15q Syndrome market in
2025.
USD 9.84 million in 2020 and is expected to rise in the forecast period.
The Dup15q Syndrome market is expected to grow by factors like an increase in the patient pool, expected entry of emerging therapy, i.e., Soticlestat (OV935/TAK-935), and deeper penetration of pharma companies in the 7MM.
Tourette Syndrome Market Comprehensive Study Explores Huge Growth In Future – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.